A Review of Practical Issues on the Use of Glucagon-Like Peptide-1 Receptor Agonists for the Management of Type 2 Diabetes
Diabetes Therapy - United States
doi 10.1007/s13300-018-0535-9
Full Text
Open PDFAbstract
Available in full text
Date
November 30, 2018
Authors
Publisher
Springer Science and Business Media LLC